EIN 38-3199649

Cascade Hemophilia Consortium

IRS 501(c) type
501(c)(3)
Num. employees
19
Year formed
1996
Most recent tax filings
2022-12-01
NTEE code, primary
Description
Cascade provides confidential home delivery of a comprehensive range of products, including all brands of factor concentrate and ancillary supplies, as well as hepatitis and HIV medications.
Total revenues
$19,811,824
2022
Total expenses
$9,799,579
2022
Total assets
$74,199,942
2022
Num. employees
19
2022

Program areas at Cascade Hemophilia Consortium

Makes products available to Hemophilia patients, assists patients without adequate insurance, works with manufacturers to obtain drugs under compassionate use policies, provides allied health services and grant contracts to organizations to provide medical care and allied health services.
Cascade serves as a contract pharmacy for several nonprofit health care organizations, receiving a fee for fulfillment of prescriptions for blood factor.
Sale of blood products, hiv and hepatitis c related therapies and other medications, at reduced prices.
Cascades exempt purpose is to enhance the system of care for Hemophilia patients by providing these products.
Rebates received from pharmaceutical companies based on amount of certain factor purchased.
Other related income.

Grants made by Cascade Hemophilia Consortium

GranteeGrant descriptionAmount
Hemophilia Foundation of MichiganRegional Core Center Support Grant$637,500
Hemophilia Foundation of MichiganSupport for Springfest, Camp Bold Eagle, NHF Annual Meeting, Eagle Expedition, and Other Regional Core Services$356,413
Michigan State UniversitySupport for Medical Services for Persons With Hemophilia and Related Bleeding Disorders$276,125
...and 15 more grants made

Personnel at Cascade Hemophilia Consortium

NameTitleCompensation
Stephanie RaymondExecutive Director$212,063
Melissa LaustroerDirector of Operations and Human Resources
Chelsea LovesFinance Director
Dean M. HindenlangDirector of Public Policy and Strategic Initiatives$140,100
Michael Altese, PharmdPharmacy Director
...and 7 more key personnel

Financials for Cascade Hemophilia Consortium

RevenuesFYE 12/2022
Total grants, contributions, etc.$120
Investment income and dividends$261,396
Net rental income$0
Net gain from sale of non-inventory assets$0
Gross sales of inventory$14,901,466
Miscellaneous revenues$4,648,842
Total revenues$19,811,824

Form 990s for Cascade Hemophilia Consortium

Fiscal year endingDate received by IRSFormPDF link
2022-122023-08-01990PFView PDF
2021-122022-04-06990PFView PDF
2020-122021-08-18990PFView PDF
2019-122020-10-15990PRView PDF
2018-122019-11-21990PFView PDF
...and 8 more Form 990s
Data update history
October 7, 2023
Posted financials
Added Form 990PF for fiscal year 2022
August 9, 2023
Posted financials
Added Form 990PF for fiscal year 2021
April 27, 2023
Updated personnel
Identified 7 new personnel
April 20, 2022
Updated personnel
Identified 14 new personnel
April 6, 2022
Posted financials
Added Form 990PF for fiscal year 2020
Nonprofit Types
Grantmaking organizationsPrivate foundationsPrivate operating foundationsCharities
Issues
HealthEducationDiseases and disorders
Characteristics
Provides grantsPartially liquidatedCommunity engagement / volunteeringTax deductible donations
General information
Address
2025 Traverwood Drive Suite A
Ann Arbor, MI 48105
Metro area
Ann Arbor, MI
Website URL
cascadehc.org/ 
Phone
(800) 996-2575
IRS details
EIN
38-3199649
Fiscal year end
December
Taxreturn type
Form 990-PF
Year formed
1996
Eligible to receive tax-deductible contributions (Pub 78)
Yes
Categorization
NTEE code, primary
T20: Private Foundations
NAICS code, primary
813211: Grantmaking Foundations
Parent/child status
Independent
Free account sign-up

Want updates when Cascade Hemophilia Consortium has new information, or want to find more organizations like Cascade Hemophilia Consortium?

Create free Cause IQ account